To provide mechanistic insight into the probability of losartan being effective as a treatment for OI we compared the gene expression profiles of the angiotensin and TGFβ signalling pathways in fibroblasts form Type 1 OI patients compared with healthy controls (Fig. 1). The gene discussed is TGFB1; the disease is osteogenesis imperfecta type 1.